Averill Madison Master Fund, Ltd.

10% OwnerBenitec Biopharma Inc. (BNTC) · full profile →Form 4 · filed Dec 22, 2025
Net Buying
Open-Market Buys
$539K
Open-Market Sells
$0
Net Open-Market Flow
$539K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 22, 2025Buy(P)17K$12.08$201K9.6M
Dec 22, 2025Buy(P)3K$12.08$35K1.8M
Dec 19, 2025Buy(P)2K$11.48$28K1.8M
Dec 19, 2025Buy(P)14K$11.48$160K9.6M
Dec 18, 2025Buy(P)9K$11.24$98K9.5M
Dec 18, 2025Buy(P)2K$11.24$17K1.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899140-25-001459) within minutes of acceptance. Every field above traces to the original document. Verify it directly: